Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis
A.W.M. Evers
Departments of Medical Psychology
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP. Duller
Departments of Medical Psychology
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP.G.M. Van Der Valk
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP.C.M. Van De Kerkhof
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorA.W.M. Evers
Departments of Medical Psychology
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP. Duller
Departments of Medical Psychology
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP.G.M. Van Der Valk
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorP.C.M. Van De Kerkhof
Dermatology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Search for more papers by this authorConflicts of interest: None declared.
Summary
Background Chronic skin diseases, such as atopic dermatitis and psoriasis, are known to affect quality of life by heightening psychological distress. Knowledge about factors contributing to psychological distress is essential for supporting physicians in diagnostic and multidisciplinary treatment options for patients psychologically at risk.
Objectives To examine whether generic physical, psychological and social factors relevant to patients with chronic diseases might contribute to psychological distress in adults with psoriasis and atopic dermatitis.
Methods Self-report data on clinical skin status, physical symptoms of itching and fatigue, impact of the disease on daily life, illness cognitions and social support were collected from 128 patients with psoriasis and 120 patients with atopic dermatitis (aged over 16 years).
Results For patients with either skin disease, clinical status and physical symptoms of itching scarcely affected psychological distress. Instead, higher levels of fatigue, perceived helplessness and less social support best predicted psychological distress in patients with both skin diseases in multiple regression analyses.
Conclusions Results demonstrate that generic physical, psychological and social aspects play a role in chronic skin diseases and suggest that multidisciplinary care for patients with psoriasis and atopic dermatitis can be greatly improved by integrating common screening and treatment components for chronic diseases.
References
- 1 Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 4: 425–9.DOI: 10.1016/0277-9536(85)90021-8
- 2 Badia X, Mascaró JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. Br J Dermatol 1999; 141: 698–702.
- 3 Linnet J, Jemec GBE. An assessment of anxiety and dermatological life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140: 268–72.DOI: 10.1046/j.1365-2133.1999.02661.x
- 4 Lundberg L, Johannesson M, Silverdahl M et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol (Stockh) 2000; 80: 430–4.DOI: 10.1080/000155500300012873
- 5 Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life. Results of a 1998 National Psoriasis Foundation Patient-membership Survey. Arch Dermatol 2001; 137: 280–4.
- 6 Kiebert G, Sorenson SV, Revicki D et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151–8.DOI: 10.1046/j.1365-4362.2002.01436.x
- 7 Weiss SC, Kimball AB, Liewehr DJ et al. Quantifying the harmful effects of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512–18.DOI: 10.1067/mjd.2002.122755
- 8 Cassileth BR, Lusk EJ, Strouse TB et al. Psychosocial status in chronic illness. A comparative analyses of six diagnostic groups. N Engl J Med 1984; 311: 506–11.
- 9 Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989; 155: 686–91.
- 10 Picarda A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983–91.DOI: 10.1046/j.1365-2133.2000.03831.x
- 11 Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001; 28: 419–23.
- 12 Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatization to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11–15.DOI: 10.1016/S0022-3999(00)00210-5
- 13 Akay A, Pekcanlar A, Bozdag KE et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002; 16: 347–52.DOI: 10.1046/j.1468-3083.2002.00467.x
- 14 Fortune DG, Richards HL, Griffiths CEM, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157–74.DOI: 10.1348/014466502163949
- 15 Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752–6.DOI: 10.1001/archderm.139.6.752
- 16 Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav 2000; 70: 567–71.DOI: 10.1016/S0031-9384(00)00290-0
- 17 Yosipovitch G, Goon A, Wee J et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143: 969–73.DOI: 10.1046/j.1365-2133.2000.03829.x
- 18 Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol 2003; 111: 598–602.
- 19 Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z et al. The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust miles. Allergy 2002; 57: 919–25.DOI: 10.1034/j.1398-9995.2002.23708.x
- 20 Stanton AL, Collins CA, Sworowski LA. Adjustment to chronic illness. Theory and research. In: Handbook of Health Psychology ( A Baum, TA Revenson, JE Singer, eds). London: Lawrence Erlbaum, 2001; 387–403.
- 21 Main CJ, Richards HL, Fortune DG. Why put new wine in old bottles: the need for a biopsychosocial approach to the assessment, treatment, and understanding of unexplained and explained symptoms in medicine. J Psychosom Res 2000; 48: 511–14.DOI: 10.1016/S0022-3999(00)00081-7
- 22 Evers AWM, Taal E, Kraaimaat FW et al. A comparison of two recently developed health status instruments for patients with arthritis: Dutch-AIMS and IRGL. Br J Rheumatol 1998; 37: 157–64.DOI: 10.1093/rheumatology/37.2.157
- 23 Evers AWM, Kraaimaat FW, Geenen R et al. Long-term predictors of anxiety and depressed mood in early rheumatoid arthritis: a 3 and 5-year follow-up. J Rheumatol 2002; 29: 2327–36.
- 24 Wahl A, Moum T, Hanestad BR, Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res 1999; 8: 319–26.DOI: 10.1023/A:1008935921866
- 25 Leventhal H, Nerenz DR, Steele DJ. Illness representations as coping with health threats. In: Handbook of Psychology and Health ( A Baum, SE Taylor, JE Singer, eds), Vol. 4. Hilsdale, NJ: Lawrence Erlbaum, 1984: 219–52.
- 26 Evers AWM, Van Kraaimaat FW, Lankveld W et al. Beyond unfavorable thinking: the Illness Cognition Questionnaire for chronic diseases. J Consult Clin Psychol 2001; 69: 1026–36.DOI: 10.1037//0022-006X.69.6.1026
- 27 Fortune DG, Richards HL, Griffiths CEM, Main CJ. Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 2004; 43: 65–82.DOI: 10.1348/014466504772812977
- 28 Cohen S, Wills TA. Stress, social support and the buffering hypothesis. Psychol Bull 1985; 98: 310–57.DOI: 10.1037//0033-2909.98.2.310
- 29 Wills TA, Filer M. Social networks and social support. In: Handbook of Health Psychology ( A Baum, TA Revenson, JE Singer, eds). London: Lawrence Erlbaum, 2001; 209–34.
- 30 Van Der Ploeg HM, Defares PB, Spielberger CD. Handleiding bij de ZelfBeoordelingsVragenlijst ZBV, 2e druk [Manual to the ZelfBeoordelingsVragenlijst ZBV, 2nd edn.]. Lisse, NL: Swets & Zeitlinger, 2000.
- 31 Zwart F, Spooren J. Ontwikkeling van een zelfbeoordelingsvragenlijst voor depressie[Development of a self-report questionnaire for depression]. Utrecht: University Medical Center Utrecht, 1982.
- 32 Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995; 63: 624–35.DOI: 10.1037//0022-006X.63.4.624
- 33 Kabat-Zinn J, Wheeler E, Light T et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 1998; 60: 625–32.
- 34 Fortune DG, Richards HL, Kirby B et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002; 146: 458–65.DOI: 10.1046/j.1365-2133.2002.04622.x
- 35 Scharloo M, Kaptein AA, Weinman J et al. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142: 899–907.DOI: 10.1046/j.1365-2133.2000.03469.x
- 36 Evers AWM, Van Kraaimaat FW, Riel PLCM, De Jong AJL. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized, controlled trial. Pain 2002; 100: 141–53.DOI: 10.1016/S0304-3959(02)00274-9
